Literature DB >> 28244845

Incidence, 10-year recidivism rate and prognostic factors for cholesteatoma.

A Britze1, M L Møller1, T Ovesen2.   

Abstract

OBJECTIVE: Cholesteatoma patients have a high risk of recurrence with complications, and knowledge exchange is a prerequisite for improving treatment. This study aimed to apply appropriate statistics to provide meaningful and transferable results from cholesteatoma surgery, to highlight independent prognostic factors, and to assess the incidence rate.
METHODS: Incidence rates were assessed for the district of Aarhus, Denmark. From 147 patients operated on mainly with canal wall up mastoidectomies for debuting cholesteatomas, 10-year Kaplan-Meier recidivism rates were calculated and independent prognostic factors for the recidivism were identified by Cox multivariate regression analyses.
RESULTS: Incidence rate was 6.8 per 100 000 per year. The 10-year cumulative recidivism rate was 0.44 (95 per cent confidence interval, 0.37-0.53). Independent prognostic factors for the recidivism were: age below 15 years (hazard ratio = 2.2; p > z = 0.002), cholesteatoma localised to the mastoid (hazard ratio = 1.7; p > z = 0.04), stapes erosion (hazard ratio = 1.9; p > z = 0.02) and incus erosion (hazard ratio = 1.9; p > z = 0.04).
CONCLUSION: The recidivism rate is influenced by several factors that are important to observe, both in the clinic and when comparing results from surgery.

Entities:  

Keywords:  Audiometry; Cholesteatoma; Incidence; Recurrence; Risk Factors

Mesh:

Year:  2017        PMID: 28244845     DOI: 10.1017/S0022215117000299

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  6 in total

1.  Predictive Role of Ki-67 and Proliferative-Cell Nuclear Antigen (PCNA) in Recurrent Cholesteatoma.

Authors:  Ela Araz Server; Çiğdem Kalaycık Ertugay; Sevim Baykal Koca; Ecem Sevim Longur; Özgür Yiğit; Hasan Demirhan; Yasemin Çakır
Journal:  J Int Adv Otol       Date:  2019-04       Impact factor: 1.017

2.  Mastoid obliteration with hydroxyapatite vs. bone pâté in mastoidectomy surgery performed on patients with cholesteatoma and chronic suppurative otitis media: a retrospective analysis.

Authors:  Jantine J Lindeboom; P M W van Kempen; J Buwalda; B O Westerlaken; D A van Zuijlen; S J H Bom; F B van der Beek
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-09-29       Impact factor: 3.236

3.  Rate of chronic otitis media operations and cholesteatoma surgeries in South Korea: a nationwide population-based study (2006-2018).

Authors:  Gi Jung Im; Kyung do Han; Kyung Ho Park; Chang Hyun Cho; Hyunsook Jang; Jun Ho Lee; Seung Hwan Lee
Journal:  Sci Rep       Date:  2020-07-09       Impact factor: 4.379

4.  Assessing the Prognostic Value of the ChOLE Classification in Predicting the Severity of Acquired Cholesteatoma.

Authors:  Maura C Eggink; Maarten J F de Wolf; Fenna A Ebbens; Frederik G Dikkers; Erik van Spronsen
Journal:  Otol Neurotol       Date:  2022-04-01       Impact factor: 2.311

Review 5.  Review of potential medical treatments for middle ear cholesteatoma.

Authors:  Matthias Schürmann; Peter Goon; Holger Sudhoff
Journal:  Cell Commun Signal       Date:  2022-09-19       Impact factor: 7.525

6.  Delays in surgery for cholesteatoma due to COVID-19: is there an impact on rates of recidivism and major complications?

Authors:  Mohammed Hassan Hussain; Manish Mair; Sara Mahmood; Georgios Sakagiannis; Djamila M Rojoa; Firas J Raheman; Esmee Irvine; Peter Rea
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-10-10       Impact factor: 2.503

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.